Trending News

FDA Roundup: December 27, 2024

FDA Roundup: December 27, 2024

For Immediate Release: December 27, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Thursday, the FDA announced recommended changes to labeling for transmucosal buprenorphine products indicated to treat opioid use disorder. The recommended changes intend to encourage the submission of...

New Hope for Stomach Cancer: Combining Immunotherapy and Chemotherapy Before Surgery

New Hope for Stomach Cancer: Combining Immunotherapy and Chemotherapy Before Surgery

What Did the Research Discover? Gastric and gastroesophageal junction (G/GEJ) cancers are among the deadliest cancers, and while immunotherapy has become a standard treatment for advanced cases, its role in earlier-stage disease is not well understood. The PANDA trial investigated whether neoadjuvant (before surgery) immunotherapy combined with chemotherapy could...

Elafibranor: A Promising New Treatment for Primary Biliary Cholangitis

Elafibranor: A Promising New Treatment for Primary Biliary Cholangitis

What Did the Research Discover? Primary biliary cholangitis (PBC) is a rare liver disease that gradually damages the bile ducts, leading to liver scarring. If left untreated, it can progress to cirrhosis and severe liver disease. The current first-line treatment, ursodeoxycholic acid (UDCA), does not work for up to 40% of patients, and the second-line option,...

Effective Treatments for Post-Inflammatory Hyperpigmentation in People with Darker Skin Tones

Effective Treatments for Post-Inflammatory Hyperpigmentation in People with Darker Skin Tones

What Did the Research Discover? Post-inflammatory hyperpigmentation (PIH) is a condition where dark spots appear on the skin after an injury, inflammation, or irritation. It is especially challenging to treat in people with darker skin tones (Fitzpatrick skin types IV-VI) because their skin naturally has more melanin, which can make treatments more difficult and...

Risk Factors for Chronic Low Back Pain: What You Should Know

Risk Factors for Chronic Low Back Pain: What You Should Know

What did the research discover? This study found that nearly one-third (32%) of patients with acute low back pain (LBP) transitioned to chronic LBP within six months. The risk of developing chronic pain was significantly associated with: Higher scores on the Subgroups for Targeted Treatment Back Tool (SBT), which predicts persistent functional limitations. Exposure...

Magnetic Seizure Therapy: A Promising Treatment for Major Depression

Magnetic Seizure Therapy: A Promising Treatment for Major Depression

What did the research discover? Researchers studied two different treatments for major depressive disorder (MDD): Magnetic Seizure Therapy (MST) and Electroconvulsive Therapy (ECT). They wanted to see which one worked better for treating depression and which had fewer effects on memory and thinking skills. The study gathered data from 10 different studies, including...